Tutkijat / Institutions  | Aarnio, M(arkku) (KSSHP) |
| Alafuzoff, I. (Uppsala) |
| Aro, A. (THL) |
| Aromaa, A. (THL) |
| Arvas, M(ikko) (Veripalvelu) |
| Bamford, D.H. (UH Viikki Campus) |
| Butcher, S. (UH Viikki Campus) |
| Cerullo, V. (UH Viikki Campus) |
| Ekblom-Kullberg, S(usanne) (Veripalvelu) |
| Eskola, J. (THL) |
| Finel, M(oshe) (UH Viikki Campus) |
| Gahmberg, C.G. (UH Viikki Campus) |
| Haimila, K(atri) (Veripalvelu) |
| Häkkinen, U. (THL) |
| Hanski, I(lkka) (1953-2016) (UH Viikki Campus) |
| Hari, R. (Aalto) |
| Havulinna, A(ki) S. (THL) |
| Hemminki, E. (THL) |
| Hiltunen, L(eena) (Veripalvelu) |
| Hiltunen, R(aimo) (UH Viikki Campus) |
| Holthöfer, H. (CBAS, Dublin) |
| Hovi, T. (THL) |
| Huoponen, O(uti) (Veripalvelu) |
| Huovinen, P. (THL) |
| Hyytiä, P. (THL) |
| Impola, U(lla) (Veripalvelu) |
| Jaatinen, T(aina) (Veripalvelu) |
| Jacobs, H.T. (UH Viikki Campus) |
| Jalanko, A. (THL) |
| Jalkanen, J(yrki) (KSSHP) |
| Jantunen, M. (THL) |
| Javela, K(aija) (Veripalvelu) |
| Joensuu, T(imo) (Docrates Cancer Center) |
| Jokela, J(orma) (Laurea) |
| Jokitalo, E. (UH Viikki Campus) |
| Jousilahti, P(ekka) (THL) |
| Julkunen, I. (THL) |
| Juppo, A(nne) (UH Viikki Campus) |
| Kääriäinen, H. (THL) |
| Kaartinen, T(anja) (Veripalvelu) |
| Kairemo, K(alevi) (Docrates) |
| Kallioniemi, O(lli) (SciLifeLab) |
| Karvonen, M. (THL) |
| Kayhty, H. (THL) |
| Kerkelä, E(rja) (Veripalvelu) |
| Keskimäki, I. (THL) |
| Kiianmaa, K. (THL) |
| Kinnunen, P.K. (Aalto) |
| Kirjavainen, V(esa) (Veripalvelu) |
| Klaukka, T. (Kela) |
| Korhonen, M(atti) (Veripalvelu) |
| Koskela, S(atu) (Veripalvelu) |
| Koskinen, S(eppo) (THL) |
| Kovanen, P.T. (Wihuri) |
| Kyrölä, K(ati) (KSSHP) |
| Laatikainen, T(iina) (THL) |
| Lähteenmäki, K(aarina) (Veripalvelu) |
| Laitinen, S(aara) (Veripalvelu) |
| Lappalainen, P. (UH Viikki Campus) |
| Larjo, A(ntti) (Veripalvelu) |
| Lauronen, J(ouni) (Veripalvelu) |
| Lehtinen, M(atti) (THL) |
| Leino-Arjas, P. (TTL) |
| Leinonen, M. (THL) |
| Lindros, K. (THL) |
| Linjama, T(iina) (Veripalvelu) |
| Lönnqvist, J. (THL) |
| Mäkelä, M. (THL) |
| Mäkelä, P.H. (THL) |
| Malmivaara, A(ntti) (THL) |
| Männistö, P. (UH Viikki Campus) |
| Mattila, P. (PSHP) |
| Mattila, P(irkko) (Veripalvelu/FIMM) |
| Mättö, J(aana) (Veripalvelu) |
| Natunen, S(uvi) (Veripalvelu) |
| Nissinen, A. (THL) |
| Nystedt, J(ohanna) (Veripalvelu) |
| Ovaskainen. M.L (THL). |
| Palosuo, T. (THL) |
| Palva, A(iri) (UH Viikki Campus) |
| Partanen, J(ukka) (Veripalvelu) |
| Partonen, T. (THL) |
| Patja, K. (THL) |
| Peltonen, M(arkku) (THL) |
| Peräsaari, J(uha) (Veripalvelu) |
| Pietinen, P. (THL) |
| Prattala, R. (THL) |
| Puska, P. (THL) |
| Qiao, Q(ing) (THL) |
| Reunanen, A. (THL) |
| Riihimäki, H. (TTL) |
| Ritari, J(armo) (Veripalvelu) |
| Ruotsalainen, P. (THL) |
| Ruskoaho, H(eikki) (UH Viikki Campus) |
| Ruutu, P. (THL) |
| Saarma, M. (UH Viikki Campus) |
| Saarni, S.I. (THL) |
| Saikku, P. (THL) |
| Sainio, S(usanna) (Veripalvelu) |
| Salomaa, V(eikko) (THL) |
| Shimmi, O. (UH Viikki Campus) |
| Siitonen, A. (THL) |
| Solantaus, T. (THL) |
| Thesleff, I. (UH Viikki Campus) |
| Tuomisto, J. (THL) |
| Uutela, A. (THL) |
| Vaarala, O. (THL) |
| Valsta, L. (THL) |
| Vartiainen, E(rkki) (THL) |
| Vartiainen, T. (THL) |
| Vasankari, T(ommi) (UKK) |
| Viikari-Juntura, E. (TTL) |
| Virtamo, J. (THL) |
| Virtanen, S.M. (THL) |
| Vuopio, J. (THL) |
| Wahlbeck, K. (THL) |
| Wikström, M. (UH Viikki Campus) |
Scholar Chart >>
|
»My Articles
»Latest Feeds
»Popular Feeds |
| | Serum Fatty Acids and Risk of Developing Islet Autoimmunity: A Nested Case-Control Study Within the TRIGR Birth Cohortss | Vaarala, O. (THL) | 47 days | save |  |  |  |  |
| A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis | Vaarala, O. (THL) | 47 days | save | | | | |
| Ultrasensitive DNA Immune Repertoire Sequencing Using Unique Molecular Identifiers | Vaarala, O. (THL) | 47 days | save | | | | |
| No evidence of autoimmunity to human OX<sub>1</sub> or OX<sub>2</sub> orexin receptors in Pandemrix-vaccinated narcoleptic children | Vaarala, O. (THL) | 47 days | save | | | | |
| Tissue Infiltrating LTi-Like Group 3 Innate Lymphoid Cells and T Follicular Helper Cells in Graves' and Hashimoto's Thyroiditis | Vaarala, O. (THL) | 47 days | save | | | | |
| Fungal Dysbiosis and Intestinal Inflammation in Children With Beta-Cell Autoimmunity | Vaarala, O. (THL) | 47 days | save | | | | |
| Elevated serum chemokine CCL22 levels in first-episode psychosis: associations with symptoms, peripheral immune state and in vivo brain glial cell function | Vaarala, O. (THL) | 47 days | save | | | | |
| Dual Role For A MEK Inhibitor As A Modulator Of Inflammation And Host Defense Mechanisms With Potential Therapeutic Application In COPD | Vaarala, O. (THL) | 47 days | save | | | | |
| Serum 25-hydroxyvitamin D concentration in childhood and risk of islet autoimmunity and type 1 diabetes: the TRIGR nested case-control ancillary study | Vaarala, O. (THL) | 47 days | save | | | | |
| LFRET, a novel rapid assay for anti-tissue transglutaminase antibody detection | Vaarala, O. (THL) | 47 days | save | | | | |
| Maturation of Gut Microbiota and Circulating Regulatory T Cells and Development of IgE Sensitization in Early Life | Vaarala, O. (THL) | 47 days | save | | | | |
| Dynamics of IFN-β Responses during Respiratory Viral Infection. Insights for Therapeutic Strategies | Vaarala, O. (THL) | 47 days | save | | | | |
| MEK inhibition drives anti-viral defence in RV but not RSV challenged human airway epithelial cells through AKT/p70S6K/4E-BP1 signalling | Vaarala, O. (THL) | 47 days | save | | | | |
| Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus | Vaarala, O. (THL) | 47 days | save | | | | |
| Gain-of-function CEBPE mutation causes noncanonical autoinflammatory inflammasomopathy | Vaarala, O. (THL) | 47 days | save | | | | |
| Exposure to sewage water and the development of allergic manifestations in Finnish children | Vaarala, O. (THL) | 47 days | save | | | | |
| IL-17-high asthma with features of a psoriasis immunophenotype | Vaarala, O. (THL) | 47 days | save | | | | |
| Using Novel Computed Tomography Analysis to Describe the Contribution and Distribution of Emphysema and Small Airways Disease in Chronic Obstructive Pulmonary Disease | Vaarala, O. (THL) | 47 days | save | | | | |
| Activation of group 2 innate lymphoid cells after allergen challenge in asthmatic patients | Vaarala, O. (THL) | 47 days | save | | | | |
| Immunomodulatory effects of antipsychotic treatment on gene expression in first-episode psychosis | Vaarala, O. (THL) | 47 days | save | | | | |
| No evidence of the role of early chemical exposure in the development ofβ-cell autoimmunity | Vaarala, O. (THL) | 47 days | save | | | | |
| Heterogeneity in diabetes-associated autoantibodies and susceptibility to Type 1 diabetes: lessons for disease prevention | Vaarala, O. (THL) | 47 days | save | | | | |
| Lanosterol Synthase Regulates Human Rhinovirus Replication in Human Bronchial Epithelial Cells | Vaarala, O. (THL) | 47 days | save | | | | |
| Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation | Vaarala, O. (THL) | 47 days | save | | | | |
| Bronchial extracellular matrix from COPD patients induces altered gene expression in repopulated primary human bronchial epithelial cells | Vaarala, O. (THL) | 47 days | save | | | | |
| Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial | Vaarala, O. (THL) | 47 days | save | | | | |
| Avoidance of Cow's Milk-Based Formula for At-Risk Infants Does Not Reduce Development of Celiac Disease: A Randomized Controlled Trial | Vaarala, O. (THL) | 47 days | save | | | | |
| Fatty acid status in infancy is associated with the risk of type 1 diabetes-associated autoimmunity | Vaarala, O. (THL) | 47 days | save | | | | |
| Correction: Altered regulation and expression of genes by BET family of proteins in COPD patients | Vaarala, O. (THL) | 47 days | save | | | | |
| Rotavirus Vaccination and the Risk of Celiac Disease or Type 1 Diabetes in Finnish Children at Early Life | Vaarala, O. (THL) | 47 days | save | | | | |
| Altered regulation and expression of genes by BET family of proteins in COPD patients | Vaarala, O. (THL) | 47 days | save | | | | |
| Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months | Vaarala, O. (THL) | 47 days | save | | | | |
| ω-3 fatty acids contribute to the asthma-protective effect of unprocessed cow's milk | Vaarala, O. (THL) | 47 days | save | | | | |
| Maternal diet during pregnancy and lactation and cow's milk allergy in offspring | Vaarala, O. (THL) | 47 days | save | | | | |
| Circulating Dendritic Cells, Farm Exposure and Asthma at Early Age | Vaarala, O. (THL) | 47 days | save | | | | |
| Altered Fecal Microbiota in Paediatric Inflammatory Bowel Disease | Vaarala, O. (THL) | 47 days | save | | | | |
| Narcolepsy as an autoimmune disease | Vaarala, O. (THL) | 47 days | save | | | | |
| Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus | Vaarala, O. (THL) | 47 days | save | | | | |
| Predisposition to Childhood Otitis Media and Genetic Polymorphisms within the Toll-Like Receptor 4 (TLR4) Locus | Vaarala, O. (THL) | 47 days | save | | | | |
| Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 | Vaarala, O. (THL) | 47 days | save | | | | |
| Altered activation of innate immunity associates with white matter volume and diffusion in first-episode psychosis | Vaarala, O. (THL) | 47 days | save | | | | |
| Moisture damage in home associates with systemic inflammation in children | Vaarala, O. (THL) | 47 days | save | | | | |
| Helsinki alert of biodiversity and health | Vaarala, O. (THL) | 47 days | save | | | | |
| High level of fecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6 | Vaarala, O. (THL) | 47 days | save | | | | |
| Infections in infants fed formula supplemented with bovine milk fat globule membranes | Vaarala, O. (THL) | 47 days | save | | | | |
| The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes | Vaarala, O. (THL) | 47 days | save | | | | |
| HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy | Vaarala, O. (THL) | 47 days | save | | | | |
| Antibodies to deamidated gliadin peptide in diagnosis of celiac disease in children | Vaarala, O. (THL) | 47 days | save | | | | |
| Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk | Vaarala, O. (THL) | 47 days | save | | | | |
| Whole-Genome Sequencing Identifies STAT4 as a Putative Susceptibility Gene in Classic Kaposi Sarcoma | Vaarala, O. (THL) | 47 days | save | | | | |
| | 
report | next » | | |
|
